AffaMed Therapeutics is a clinical stage therapeutic company focused on developing and commercializing transformative pharmaceutical, digital and surgical products that address critical unmet medical needs in ophthalmic, neurological and psychiatric disorders for patients in Greater China and around the world. The leadership team of AffaMed Therapeutics has gained deep industry expertise and an extensive track record in high-quality discovery, clinical development, regulatory affairs, manufacturing, commercial operations, and business development at leading multi-national pharmaceutical companies in China and globally.
Company Details
- Employees
- 39
- Founded
- -
- Address
- 288 Shimen Yi Road, Shanghai,china
- Industry
- Biotechnology
- Website
- https://www.affamed.com/
- Keywords
- Boston.
- HQ
- Shanghai
Affamed Therapeutics Questions
Affamed Therapeutics's website is https://www.affamed.com/
Affamed Therapeutics's LinkedIn profile is https://cn.linkedin.com/company/affamed-therapeutics
Affamed Therapeutics has
39 employees.
View email and phone details for 39
employees at Affamed Therapeutics.
Affamed Therapeutics's industry is
Biotechnology
Affamed Therapeutics's top competitors are
Prescient Therapeutics,
Cbc Group,
Genexine, Inc.,
Michaelis-Menten Associates,
Elion Therapeutics,
Nuance Pharma,
Ascentage Pharma,
Aethon Therapeutics,
Skyline Therapeutics,
Biosanapharma.
Affamed Therapeutics's categories are Biotechnology
Affamed Therapeutics's founding year is 2019
